ClinConnect ClinConnect Logo
Search / Trial NCT03516578

CMR for Prognosis Assessment in NSTEMI

Launched by HEART CENTER LEIPZIG - UNIVERSITY HOSPITAL · Apr 24, 2018

Trial Information

Current as of May 15, 2025

Completed

Keywords

Non St Elevation Myocardial Infarction Cardiac Magnetic Resonance Prognosis

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria: Patients are eligible for the study if they have: 1) ischemic symptoms in accordance with a possible NSTEMI diagnosis; 2) elevated cardiac troponin levels above the 99th percentile; and 3) identifiable culprit lesion during early invasive coronary angiography with performed PCI.
  • Exclusion Criteria: 1) STEMI; 2) presence of cardiogenic shock; 3) no identifiable culprit lesion or culprit lesion ineligible for PCI; 4) indication for acute bypass surgery; 5) age less than 18 years or more than 90 years; 6) pregnancy; and 7) typical contraindications to CMR (e.g. severe claustrophobia, implanted pacemakers and internal cardioverter defibrillators, cerebral or intracranial metallic implants, known allergy to gadolinium and creatinine clearance \<30 mL/min).

About Heart Center Leipzig University Hospital

Heart Center Leipzig - University Hospital is a leading medical institution specializing in cardiovascular care and research. Renowned for its commitment to advancing heart health, the center integrates cutting-edge clinical practices with innovative research initiatives. As a prominent clinical trial sponsor, it focuses on developing and evaluating new therapeutic strategies and technologies aimed at improving patient outcomes in cardiovascular diseases. The Heart Center Leipzig is dedicated to fostering collaboration between clinicians, researchers, and industry partners to enhance the understanding and treatment of heart conditions, ultimately contributing to global advancements in cardiovascular medicine.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials